Fertility Services Market to grow at a CAGR of 10.3% during 2026 to 2035; Driven by Rising Infertility Rates and Increasing Demand for Assisted Reproductive Services

Market Highlights

The Fertility Services Market closed 2025 at USD 42.35 billion and enters the forecast window at USD 46.71 billion in 2026, expanding to USD 112.88 billion by 2035 at a 10.3% CAGR. This growth is primarily driven by rising infertility rates, technological advancements in assisted reproductive technologies (ART), and changing societal norms related to family planning.

Increasing infertility cases caused by delayed childbearing, stress, lifestyle disorders, and environmental factors are fueling the demand for fertility services globally. Moreover, improvements in in-vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and cryopreservation techniques are significantly enhancing treatment outcomes and patient satisfaction.

Additionally, the growing acceptance of same-sex couples, single parents, and couples with unexplained infertility seeking fertility assistance reflects evolving social perceptions and inclusivity trends. The integration of telehealth and digital platforms is further transforming patient experiences, enabling remote consultations, monitoring, and access to specialized care.

The market is also benefitting from regulatory support and favorable insurance coverage in several regions, particularly in North America and Europe, which are expanding the affordability and accessibility of fertility treatments.

MRFR recognizes the following companies as the key players in the Global Fertility Services Market — IVF Australia (Australia), Fertility Centers of Illinois (US), CCRM Fertility (US), New Hope Fertility Center (US), Reproductive Health Specialists (US), Bourn Hall Clinic (UK), Clinica de Fertilidad (Spain), and IVF Spain (Spain).

Segment Analysis

The Global Fertility Services Market has been segmented based on Treatment Type, Patient Type, End User, Service Type, and Region.

Based on Treatment Type, the market is segmented into In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Artificial Insemination, Donor Egg, and Surrogacy. Among these, In Vitro Fertilization (IVF) dominates the market due to its proven efficacy and high success rates, while Intracytoplasmic Sperm Injection (ICSI) is expected to be the fastest-growing segment owing to its rising use in male infertility treatments.

Based on Patient Type, the market is categorized into Female Infertility, Male Infertility, Couples with Unexplained Infertility, Same-Sex Couples, and Single Parents. Female Infertility holds the largest market share, supported by strong awareness and accessibility to treatments. Meanwhile, Same-Sex Couples are emerging as a rapidly growing segment, driven by increasing societal acceptance and legal recognition in several countries.

Based on end user, the market includes Fertility Clinics, Hospitals, and Home Care.Fertility Clinics dominate the market as they offer specialized reproductive services and advanced ART facilities. However, Hospitals are projected to be the fastest-growing end-user segment due to integrated reproductive health departments and broader healthcare access.

Based on Service Type, the market is segmented into Consultation Services, Diagnostic Services, and Treatment Services. Consultation Services lead the market, as initial evaluations and counseling form the cornerstone of fertility management. Treatment Services, however, are witnessing the highest growth rate, fueled by innovations in IVF, genetic testing, and fertility preservation technologies.

Regional Insights

North America accounts for approximately 45% of the global market share. Growth is driven by advanced healthcare infrastructure, high treatment awareness, and supportive insurance frameworks such as the Affordable Care Act. The United States leads the region with key players like CCRM Fertility, New Hope Fertility Center, and Fertility Centers of Illinois, focusing on cutting-edge reproductive technologies and patient-centered care.

Europe holds about 30% of the global share, propelled by favorable regulatory environments and strong adoption of ART. Spain and the UK are the leading countries, offering cost-effective treatments and attracting international patients. The European Society of Human Reproduction and Embryology (ESHRE) promotes standardized fertility practices and research, further strengthening market growth.

Asia-Pacific is projected to grow at the fastest rate, accounting for around 20% of the market by 2035. Rising infertility rates, urbanization, and improved healthcare infrastructure in India, China, Japan, and Australia are driving regional demand. Affordable treatment options and government support for reproductive healthcare are key factors fueling expansion.

The Middle East and Africa represent about 5% of the global market. Growth is driven by rising infertility awareness, supportive regulations, and increasing numbers of specialized fertility centers in South Africa and the UAE.

Key Findings of the Study

• Dedicated fertility clinics account for 61.8% of global spend within the Fertility Services Market.


• Hospital-based reproductive units generated USD 12.03 billion in 2025, leaning on integrated obstetric pathways.


• North America contributed USD 16.30 billion in 2025, led by employer-sponsored benefit expansion.


• Asia-Pacific posts a 12.8% CAGR, the fastest of any region


• Middle East & Africa holds 4.5% share, with Gulf medical-tourism corridors driving disproportionate growth